R&D Targeting COVID-19 and cancer with immunotherapy advancement... Anna Biosciences’ Dr Anthony Rullo discusses the drug development company’s immunotherapy platform.
News European Commission approves 2nd IPCEI to sum of €403m The European Commission has approved, under EU State aid rules, the second health-related IPCEI to support innovations in medical devices.
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face
